Apellis’s Syfovre becomes the first FDA-approved drug for geographic atrophy

March 4, 2023

Five Things to Know in October Third & Fourth Week

December 10, 2022

Sun and Taro reach an agreement on $348M buyout after 17 years

January 22, 2024

Must Read

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

April 25, 2026

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

April 25, 2026

Pfizer Stops Work on Next-Gen Drug For Cancer Patients

April 25, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Pfizer Stops Work on Next-Gen Drug For Cancer Patients

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Commercial

Gilead, Merck and other big pharmas engaged in illicit “pay-for-delay” deals to retain their lucrative HIV and cholesterol meds supremacy

Editor Picks

Apellis’s Syfovre becomes the first FDA-approved drug for geographic atrophy

Five Things to Know in October Third & Fourth Week

Sun and Taro reach an agreement on $348M buyout after 17 years

Must Read

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Pfizer Stops Work on Next-Gen Drug For Cancer Patients

Hot Topics

About Us

Follow Us